H-3926.1
HOUSE BILL 2745
State of Washington | 66th Legislature | 2020 Regular Session |
ByRepresentatives Fey, Appleton, and Davis
Read first time 01/20/20.Referred to Committee on Health Care & Wellness.
AN ACT Relating to requiring the department of health to conduct a study on treatments for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections; creating a new section; and providing an expiration date.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
NEW SECTION. Sec. 1. (1) By December 1, 2020, the department of health shall submit to the legislature a report that summarizes the available treatments for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and the treatments' effectiveness. The report must include:
(a) A description of the disease and its symptoms; and
(b) A summary of the effectiveness of treating pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections using any standard, experimental, or emerging therapies, including:
(i) Antibiotics;
(ii) Plasma exchanges;
(iii) Intravenous immunoglobulin; and
(iv) Tonsillectomy.
(2) This section expires January 1, 2021.
--- END ---